Kelly CRISPR & Gene Editing Technology ETF – NASDAQ:XDNA

Kelly CRISPR & Gene Editing Technology ETF stock price monthly change

+22.59%
month

Kelly CRISPR & Gene Editing Technology ETF stock price quarterly change

-12.46%
quarter

Kelly CRISPR & Gene Editing Technology ETF key metrics

Market Cap
 2.58M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Kelly CRISPR & Gene Editing Technology ETF stock price history

Kelly CRISPR & Gene Editing Technology ETF stock forecast

Kelly CRISPR & Gene Editing Technology ETF financial statements

Kelly CRISPR & Gene Editing Technology ETF other data

Kelly CRISPR & Gene Editing Technology ETF
Latest News

Friday, 1 December 2023
ETF Trends
Friday, 17 November 2023
ETF Trends
Monday, 30 October 2023
Zacks Investment Research

Frequently Asked Questions (FAQ)

  • When is Kelly CRISPR & Gene Editing Technology ETF's next earnings date?

    Unfortunately, Kelly CRISPR & Gene Editing Technology ETF's (XDNA) next earnings date is currently unknown.

  • Does Kelly CRISPR & Gene Editing Technology ETF pay dividends?

    No, Kelly CRISPR & Gene Editing Technology ETF does not pay dividends.

  • How much money does Kelly CRISPR & Gene Editing Technology ETF make?

    Kelly CRISPR & Gene Editing Technology ETF has a market capitalization of 2.58M.

  • What is Kelly CRISPR & Gene Editing Technology ETF's stock symbol?

    Kelly CRISPR & Gene Editing Technology ETF is traded on the NASDAQ under the ticker symbol "XDNA".

  • What is Kelly CRISPR & Gene Editing Technology ETF's primary industry?

    Company operates in the Financial Services sector and Asset Management industry.

  • How do i buy shares of Kelly CRISPR & Gene Editing Technology ETF?

    Shares of Kelly CRISPR & Gene Editing Technology ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Kelly CRISPR & Gene Editing Technology ETF went public?

    Kelly CRISPR & Gene Editing Technology ETF is publicly traded company for more then 3 years since IPO on 13 Jan 2022.

Kelly CRISPR & Gene Editing Technology ETF company profile:

Kelly CRISPR & Gene Editing Technology ETF

Exchange:

NASDAQ

Full time employees:

0

Industry:

Asset Management

Sector:

Financial Services

The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the DNA Modification Technology Business. The fund invests at least 80% of its net assets in DNA Modification Technology Companies. It is non-diversified.


,

CIK: 0001873280
ISIN: CA46437W1059
: